2022-2029 Global Molecular Diagnostics (MDx) Point of Care Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)

Publisher Name :
Date: 14-Apr-2022
No. of pages: 123

The Molecular Diagnostics (MDx) Point of Care market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.

The report focuses on the Molecular Diagnostics (MDx) Point of Care market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.

Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Molecular Diagnostics (MDx) Point of Care market.

Key players in the global Molecular Diagnostics (MDx) Point of Care market covered in Chapter 2 and Chapter 6:

EKF Diagnostics

F. Hoffmann-La Roche AG

Mesa Biotech Inc.

Johnson & Johnson

Becton Dickinson & Company

Danaher Corporation

Siemens Healthineers

Roche Diagnostics

Luminex Corporation

Trinity Biotech

QIAGEN N.V

DxNA LLC

Hologic Inc.

Abbott Laboratories

Quidel Corporation

In Chapter 8 and Chapter 10.3, based on types, the Molecular Diagnostics (MDx) Point of Care market from 2017 to 2029 is primarily split into:

Isothermal Nucleic Acid Amplification Technology (INAAT)

Polymerase Chain Reaction (PCR)

Digital PCR

Real Time PCR

Others

In Chapter 9 and Chapter 10.4, based on applications, the Molecular Diagnostics (MDx) Point of Care market from 2017 to 2029 covers:

Infectious Diseases

Oncology

Hematology

Prenatal Testing

Endocrinology

Others

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Latin America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Molecular Diagnostics (MDx) Point of Care market, containing global revenue and CAGR. The forecast and analysis of Molecular Diagnostics (MDx) Point of Care market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 introduces the industrial chain of Molecular Diagnostics (MDx) Point of Care. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.

Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Molecular Diagnostics (MDx) Point of Care industry, consumer behavior analysis.

Chapter 6 provides a full-scale analysis of major players in Molecular Diagnostics (MDx) Point of Care industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 7 pays attention to the sales, revenue, price and gross margin of Molecular Diagnostics (MDx) Point of Care in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 gives a worldwide view of Molecular Diagnostics (MDx) Point of Care market. It includes sales, revenue, price, market share and the growth rate by type.

Chapter 9 focuses on the application of Molecular Diagnostics (MDx) Point of Care, by analyzing the consumption and its growth rate of each application.

Chapter 10 prospects the whole Molecular Diagnostics (MDx) Point of Care market, including the global sales and revenue forecast, regional forecast. It also foresees the Molecular Diagnostics (MDx) Point of Care market by type and application.

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

2022-2029 Global Molecular Diagnostics (MDx) Point of Care Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)

Table of Content

1 Molecular Diagnostics (MDx) Point of Care Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics (MDx) Point of Care
1.2 Molecular Diagnostics (MDx) Point of Care Segment by Type
1.2.1 Global Molecular Diagnostics (MDx) Point of Care Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.3 The Market Profile of Polymerase Chain Reaction (PCR)
1.2.4 The Market Profile of Digital PCR
1.2.5 The Market Profile of Real Time PCR
1.2.6 The Market Profile of Others
1.3 Global Molecular Diagnostics (MDx) Point of Care Segment by Application
1.3.1 Molecular Diagnostics (MDx) Point of Care Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Infectious Diseases
1.3.3 The Market Profile of Oncology
1.3.4 The Market Profile of Hematology
1.3.5 The Market Profile of Prenatal Testing
1.3.6 The Market Profile of Endocrinology
1.3.7 The Market Profile of Others
1.4 Global Molecular Diagnostics (MDx) Point of Care Market, Region Wise (2017-2022)
1.4.1 Global Molecular Diagnostics (MDx) Point of Care Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.3 Europe Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.3.1 Germany Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.3.2 UK Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.3.3 France Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.3.4 Italy Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.3.5 Spain Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.3.6 Russia Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.3.7 Poland Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.4 China Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.5 Japan Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.6 India Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.8 Latin America Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Molecular Diagnostics (MDx) Point of Care Market Status and Prospect (2017-2022)
1.5 Global Market Size of Molecular Diagnostics (MDx) Point of Care (2017-2029)
1.5.1 Global Molecular Diagnostics (MDx) Point of Care Revenue Status and Outlook (2017-2029)
1.5.2 Global Molecular Diagnostics (MDx) Point of Care Sales Status and Outlook (2017-2029)

2 Global Molecular Diagnostics (MDx) Point of Care Market Landscape by Player
2.1 Global Molecular Diagnostics (MDx) Point of Care Sales and Share by Player (2017-2022)
2.2 Global Molecular Diagnostics (MDx) Point of Care Revenue and Market Share by Player (2017-2022)
2.3 Global Molecular Diagnostics (MDx) Point of Care Average Price by Player (2017-2022)
2.4 Global Molecular Diagnostics (MDx) Point of Care Gross Margin by Player (2017-2022)
2.5 Molecular Diagnostics (MDx) Point of Care Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Molecular Diagnostics (MDx) Point of Care Market Competitive Situation and Trends
2.6.1 Molecular Diagnostics (MDx) Point of Care Market Concentration Rate
2.6.2 Molecular Diagnostics (MDx) Point of Care Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion

3 Molecular Diagnostics (MDx) Point of Care Upstream and Downstream Analysis
3.1 Molecular Diagnostics (MDx) Point of Care Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-18

4 Molecular Diagnostics (MDx) Point of Care Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Molecular Diagnostics (MDx) Point of Care Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Molecular Diagnostics (MDx) Point of Care Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis

5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Molecular Diagnostics (MDx) Point of Care
5.3.2 Increased Demand in Emerging Markets
5.4 Molecular Diagnostics (MDx) Point of Care Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Molecular Diagnostics (MDx) Point of Care Industry Development
5.5 Consumer Behavior Analysis

6 Players Profiles
6.1 EKF Diagnostics
6.1.1 EKF Diagnostics Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.1.3 EKF Diagnostics Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.1.4 EKF Diagnostics Business Overview
6.2 F. Hoffmann-La Roche AG
6.2.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.2.3 F. Hoffmann-La Roche AG Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.2.4 F. Hoffmann-La Roche AG Business Overview
6.3 Mesa Biotech Inc.
6.3.1 Mesa Biotech Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.3.3 Mesa Biotech Inc. Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.3.4 Mesa Biotech Inc. Business Overview
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.4.3 Johnson & Johnson Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.4.4 Johnson & Johnson Business Overview
6.5 Becton Dickinson & Company
6.5.1 Becton Dickinson & Company Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.5.3 Becton Dickinson & Company Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.5.4 Becton Dickinson & Company Business Overview
6.6 Danaher Corporation
6.6.1 Danaher Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.6.3 Danaher Corporation Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.6.4 Danaher Corporation Business Overview
6.7 Siemens Healthineers
6.7.1 Siemens Healthineers Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.7.3 Siemens Healthineers Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.7.4 Siemens Healthineers Business Overview
6.8 Roche Diagnostics
6.8.1 Roche Diagnostics Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.8.3 Roche Diagnostics Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.8.4 Roche Diagnostics Business Overview
6.9 Luminex Corporation
6.9.1 Luminex Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.9.3 Luminex Corporation Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.9.4 Luminex Corporation Business Overview
6.10 Trinity Biotech
6.10.1 Trinity Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
6.10.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.10.3 Trinity Biotech Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.10.4 Trinity Biotech Business Overview
6.11 QIAGEN N.V
6.11.1 QIAGEN N.V Basic Information, Manufacturing Base, Sales Area and Competitors
6.11.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.11.3 QIAGEN N.V Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.11.4 QIAGEN N.V Business Overview
6.12 DxNA LLC
6.12.1 DxNA LLC Basic Information, Manufacturing Base, Sales Area and Competitors
6.12.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.12.3 DxNA LLC Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.12.4 DxNA LLC Business Overview
6.13 Hologic Inc.
6.13.1 Hologic Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
6.13.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.13.3 Hologic Inc. Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.13.4 Hologic Inc. Business Overview
6.14 Abbott Laboratories
6.14.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
6.14.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.14.3 Abbott Laboratories Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.14.4 Abbott Laboratories Business Overview
6.15 Quidel Corporation
6.15.1 Quidel Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
6.15.2 Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
6.15.3 Quidel Corporation Molecular Diagnostics (MDx) Point of Care Market Performance (2017-2022)
6.15.4 Quidel Corporation Business Overview

7 Global Molecular Diagnostics (MDx) Point of Care Sales and Revenue Region Wise (2017-2022)
7.1 Global Molecular Diagnostics (MDx) Point of Care Sales and Market Share, Region Wise (2017-2022)
7.2 Global Molecular Diagnostics (MDx) Point of Care Revenue (Revenue) and Market Share, Region Wise (2017-2022)
7.3 Global Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
7.4.1 United States Molecular Diagnostics (MDx) Point of Care Market Under COVID-19
7.5 Europe Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
7.5.1 Europe Molecular Diagnostics (MDx) Point of Care Market Under COVID-19
7.6 China Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
7.6.1 China Molecular Diagnostics (MDx) Point of Care Market Under COVID-19
7.7 Japan Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
7.7.1 Japan Molecular Diagnostics (MDx) Point of Care Market Under COVID-19
7.8 India Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
7.8.1 India Molecular Diagnostics (MDx) Point of Care Market Under COVID-19
7.9 Southeast Asia Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
7.9.1 Southeast Asia Molecular Diagnostics (MDx) Point of Care Market Under COVID-19
7.10 Latin America Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
7.10.1 Latin America Molecular Diagnostics (MDx) Point of Care Market Under COVID-19
7.11 Middle East and Africa Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
7.11.1 Middle East and Africa Molecular Diagnostics (MDx) Point of Care Market Under COVID-19

8 Global Molecular Diagnostics (MDx) Point of Care Sales, Revenue (Revenue), Price Trend by Type
8.1 Global Molecular Diagnostics (MDx) Point of Care Sales and Market Share by Type (2017-2022)
8.2 Global Molecular Diagnostics (MDx) Point of Care Revenue and Market Share by Type (2017-2022)
8.3 Global Molecular Diagnostics (MDx) Point of Care Price by Type (2017-2022)
8.4 Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate by Type (2017-2022)
8.4.1 Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate of Isothermal Nucleic Acid Amplification Technology (INAAT) (2017-2022)
8.4.2 Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate of Polymerase Chain Reaction (PCR) (2017-2022)
8.4.3 Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate of Digital PCR (2017-2022)
8.4.4 Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate of Real Time PCR (2017-2022)
8.4.5 Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate of Others (2017-2022)

9 Global Molecular Diagnostics (MDx) Point of Care Market Analysis by Application
9.1 Global Molecular Diagnostics (MDx) Point of Care Consumption and Market Share by Application (2017-2022)
9.2 Global Molecular Diagnostics (MDx) Point of Care Consumption Growth Rate by Application (2017-2022)
9.2.1 Global Molecular Diagnostics (MDx) Point of Care Consumption Growth Rate of Infectious Diseases (2017-2022)
9.2.2 Global Molecular Diagnostics (MDx) Point of Care Consumption Growth Rate of Oncology (2017-2022)
9.2.3 Global Molecular Diagnostics (MDx) Point of Care Consumption Growth Rate of Hematology (2017-2022)
9.2.4 Global Molecular Diagnostics (MDx) Point of Care Consumption Growth Rate of Prenatal Testing (2017-2022)
9.2.5 Global Molecular Diagnostics (MDx) Point of Care Consumption Growth Rate of Endocrinology (2017-2022)
9.2.6 Global Molecular Diagnostics (MDx) Point of Care Consumption Growth Rate of Others (2017-2022)

10 Global Molecular Diagnostics (MDx) Point of Care Market Forecast (2022-2029)
10.1 Global Molecular Diagnostics (MDx) Point of Care Sales, Revenue Forecast (2022-2029)
10.1.1 Global Molecular Diagnostics (MDx) Point of Care Sales and Growth Rate Forecast (2022-2029)
10.1.2 Global Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate Forecast (2022-2029)
10.1.3 Global Molecular Diagnostics (MDx) Point of Care Price and Trend Forecast (2022-2029)
10.2 Global Molecular Diagnostics (MDx) Point of Care Sales and Revenue Forecast, Region Wise (2022-2029)
10.2.1 United States Molecular Diagnostics (MDx) Point of Care Sales and Revenue Forecast (2022-2029)
10.2.2 Europe Molecular Diagnostics (MDx) Point of Care Sales and Revenue Forecast (2022-2029)
10.2.3 China Molecular Diagnostics (MDx) Point of Care Sales and Revenue Forecast (2022-2029)
10.2.4 Japan Molecular Diagnostics (MDx) Point of Care Sales and Revenue Forecast (2022-2029)
10.2.5 India Molecular Diagnostics (MDx) Point of Care Sales and Revenue Forecast (2022-2029)
10.2.6 Southeast Asia Molecular Diagnostics (MDx) Point of Care Sales and Revenue Forecast (2022-2029)
10.2.7 Latin America Molecular Diagnostics (MDx) Point of Care Sales and Revenue Forecast (2022-2029)
10.2.8 Middle East and Africa Molecular Diagnostics (MDx) Point of Care Sales and Revenue Forecast (2022-2029)
10.3 Global Molecular Diagnostics (MDx) Point of Care Sales, Revenue and Price Forecast by Type (2022-2029)
10.4 Global Molecular Diagnostics (MDx) Point of Care Consumption Forecast by Application (2022-2029)
10.5 Molecular Diagnostics (MDx) Point of Care Market Forecast Under COVID-19

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Data Source

List of Tables and Figures

Figure Molecular Diagnostics (MDx) Point of Care Product Picture
Table Global Molecular Diagnostics (MDx) Point of Care Sales and CAGR (%) Comparison by Type
Table Profile of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table Profile of Polymerase Chain Reaction (PCR)
Table Profile of Digital PCR
Table Profile of Real Time PCR
Table Profile of Others
Table Molecular Diagnostics (MDx) Point of Care Consumption (Sales) Comparison by Application (2017-2029)
Table Profile of Infectious Diseases
Table Profile of Oncology
Table Profile of Hematology
Table Profile of Prenatal Testing
Table Profile of Endocrinology
Table Profile of Others
Figure Global Molecular Diagnostics (MDx) Point of Care Market Size (Revenue) and CAGR (%) (2017-2022)
Figure United States Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Europe Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Germany Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure UK Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure France Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Italy Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Spain Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Russia Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Poland Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure China Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Japan Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure India Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Malaysia Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Singapore Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Philippines Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Indonesia Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Thailand Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Vietnam Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Latin America Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Brazil Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Mexico Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Colombia Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Middle East and Africa Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Saudi Arabia Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure United Arab Emirates Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Turkey Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Egypt Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure South Africa Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Nigeria Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales Status and Outlook (2017-2029)
Table Global Molecular Diagnostics (MDx) Point of Care Sales by Player (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Sales Share by Player (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales Share by Player in 2021
Table Molecular Diagnostics (MDx) Point of Care Revenue by Player (2017-2022)
Table Molecular Diagnostics (MDx) Point of Care Revenue Market Share by Player (2017-2022)
Table Molecular Diagnostics (MDx) Point of Care Price by Player (2017-2022)
Table Molecular Diagnostics (MDx) Point of Care Gross Margin by Player (2017-2022)
Table Molecular Diagnostics (MDx) Point of Care Manufacturing Base Distribution and Sales Area by Player
Table Molecular Diagnostics (MDx) Point of Care Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Figure Molecular Diagnostics (MDx) Point of Care Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Market Concentration Rate of Raw Materials
Table Downstream Buyers
Figure Manufacturing Cost Structure Analysis
Table Key Raw Materials Introduction of Molecular Diagnostics (MDx) Point of Care
Figure Price Trend of Key Raw Materials
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Molecular Diagnostics (MDx) Point of Care Industry Development
Table EKF Diagnostics Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table EKF Diagnostics Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure EKF Diagnostics Revenue and Growth Rate
Figure EKF Diagnostics Revenue Market Share 2017-2022
Table F. Hoffmann-La Roche AG Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table F. Hoffmann-La Roche AG Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche AG Revenue and Growth Rate
Figure F. Hoffmann-La Roche AG Revenue Market Share 2017-2022
Table Mesa Biotech Inc. Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Mesa Biotech Inc. Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Mesa Biotech Inc. Revenue and Growth Rate
Figure Mesa Biotech Inc. Revenue Market Share 2017-2022
Table Johnson & Johnson Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Johnson & Johnson Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Revenue and Growth Rate
Figure Johnson & Johnson Revenue Market Share 2017-2022
Table Becton Dickinson & Company Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Becton Dickinson & Company Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Becton Dickinson & Company Revenue and Growth Rate
Figure Becton Dickinson & Company Revenue Market Share 2017-2022
Table Danaher Corporation Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Danaher Corporation Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Danaher Corporation Revenue and Growth Rate
Figure Danaher Corporation Revenue Market Share 2017-2022
Table Siemens Healthineers Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Siemens Healthineers Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Siemens Healthineers Revenue and Growth Rate
Figure Siemens Healthineers Revenue Market Share 2017-2022
Table Roche Diagnostics Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Roche Diagnostics Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Roche Diagnostics Revenue and Growth Rate
Figure Roche Diagnostics Revenue Market Share 2017-2022
Table Luminex Corporation Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Luminex Corporation Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Luminex Corporation Revenue and Growth Rate
Figure Luminex Corporation Revenue Market Share 2017-2022
Table Trinity Biotech Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Trinity Biotech Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Trinity Biotech Revenue and Growth Rate
Figure Trinity Biotech Revenue Market Share 2017-2022
Table QIAGEN N.V Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table QIAGEN N.V Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure QIAGEN N.V Revenue and Growth Rate
Figure QIAGEN N.V Revenue Market Share 2017-2022
Table DxNA LLC Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table DxNA LLC Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure DxNA LLC Revenue and Growth Rate
Figure DxNA LLC Revenue Market Share 2017-2022
Table Hologic Inc. Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Hologic Inc. Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Hologic Inc. Revenue and Growth Rate
Figure Hologic Inc. Revenue Market Share 2017-2022
Table Abbott Laboratories Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Abbott Laboratories Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Abbott Laboratories Revenue and Growth Rate
Figure Abbott Laboratories Revenue Market Share 2017-2022
Table Quidel Corporation Profile
Table Molecular Diagnostics (MDx) Point of Care Product Profiles, Application and Specification
Table Quidel Corporation Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Quidel Corporation Revenue and Growth Rate
Figure Quidel Corporation Revenue Market Share 2017-2022
Table Global Molecular Diagnostics (MDx) Point of Care Sales, Region Wise (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Sales Market Share, Region Wise (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales Market Share, Region Wise (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales Market Share, Region Wise in 2021
Table Global Molecular Diagnostics (MDx) Point of Care Revenue, Region Wise (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Revenue Market Share, Region Wise (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Revenue Market Share, Region Wise (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Revenue Market Share, Region Wise in 2021
Table Global Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Table United States Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Table Europe Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Table China Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Table Japan Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Table India Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Table Southeast Asia Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Table Latin America Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Table Middle East and Africa Molecular Diagnostics (MDx) Point of Care Sales, Revenue, Price and Gross Margin (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Sales by Type (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Sales Market Share by Type (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales Market Share by Type in 2022
Table Global Molecular Diagnostics (MDx) Point of Care Revenue by Type (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Revenue Market Share by Type (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Revenue Market Share by Type in 2022
Table Molecular Diagnostics (MDx) Point of Care Price by Type (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate of Isothermal Nucleic Acid Amplification Technology (INAAT) (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate of Polymerase Chain Reaction (PCR) (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate of Digital PCR (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate of Real Time PCR (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales Growth Rate of Others (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Consumption by Application (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Consumption Market Share by Application (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Consumption of Infectious Diseases (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Consumption of Oncology (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Consumption of Hematology (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Consumption of Prenatal Testing (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Consumption of Endocrinology (2017-2022)
Table Global Molecular Diagnostics (MDx) Point of Care Consumption of Others (2017-2022)
Figure Global Molecular Diagnostics (MDx) Point of Care Sales and Growth Rate Forecast (2022-2029)
Figure Global Molecular Diagnostics (MDx) Point of Care Revenue and Growth Rate Forecast (2022-2029)
Figure Global Molecular Diagnostics (MDx) Point of Care Price and Trend Forecast (2022-2029)
Figure USA Molecular Diagnostics (MDx) Point of Care Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure USA Molecular Diagnostics (MDx) Point of Care Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Molecular Diagnostics (MDx) Point of Care Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Molecular Diagnostics (MDx) Point of Care Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure China Molecular Diagnostics (MDx) Point of Care Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure China Molecular Diagnostics (MDx) Point of Care Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Molecular Diagnostics (MDx) Point of Care Market Sales and Growth Rate Forecast Analys
  • Global Cytokine Inhibitor Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......
  • Global Microbial Growth Media Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......
  • Global Protein Biochip Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......
  • Global Isothermal Nucleic Acid Amplification Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103
    Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......
  • Global Microfluidics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......
  • Global Cytokines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......
  • Global Western Blot Imagers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......
  • Global Procalcitonin Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs